Organogenesis Holdings Inc.
ORGO Nasdaq
SEC CIK 1661181
Follow Organogenesis
Weekly email: filings, results
Revenue, last quarter
$45.5M
−69.9% vs same quarter last year
Net income
−$29.6M
−237.4% vs same quarter last year
EPS, diluted
−$0.25
−327.3% vs same quarter last year
Operating cash flow
−$18.6M
−703.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $564.2M | $37M |
| FY24 | $482M | $900K |
| FY23 | $433.1M | $4.9M |
| FY22 | $450.9M | $15.5M |
| FY21 | $467.4M | $94.2M |
| FY20 | $338.3M | $17.2M |
| FY19 | $261M | −$38.7M |
| FY18 | $193.4M | −$64.8M |
| FY17 | $198.5M | −$8.4M |
| FY16 | $138.7M | −$17M |
| FY15 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | 7.9% | 6.6% |
| FY24 | 76% | −0.3% | 0.2% |
| FY23 | 75.4% | 2.9% | 1.1% |
| FY22 | 76.7% | 4.9% | 3.4% |
| FY21 | 75.6% | 15.5% | 20.2% |
| FY20 | 74.2% | 7.9% | 5.1% |
| FY19 | 70.9% | −11.4% | −14.8% |
| FY18 | 64.4% | −26.7% | −33.5% |
| FY17 | 69.2% | −2.8% | −4.2% |
| FY16 | 65.3% | −6.3% | −12.2% |
| FY15 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$24.5M |
| FY24 | $4.2M |
| FY23 | $6.6M |
| FY22 | −$9M |
| FY21 | $30.8M |
| FY20 | −$12.2M |
| FY19 | −$39.5M |
| FY18 | −$62.5M |
| FY17 | −$5.9M |
| FY16 | −$6.2M |
| FY15 | - |
Show the numbers
| Year | Buybacks |
|---|---|
| FY25 | - |
| FY24 | $25.5M |
| FY23 | $0 |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
- Organogenesis
- Healthcare median
Show the numbers
| Year | Organogenesis | Healthcare median |
|---|---|---|
| FY25 | 6.6% | −30.6% |
| FY24 | 0.2% | −47% |
| FY23 | 1.1% | −58% |
| FY22 | 3.4% | −80.4% |
| FY21 | 20.2% | −71.8% |
| FY20 | 5.1% | −62.2% |
| FY19 | −14.8% | −46.2% |
| FY18 | −33.5% | −49.6% |
| FY17 | −4.2% | −45.9% |
| FY16 | −12.2% | −36% |
| FY15 | - | −37.8% |